These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 2251197)

  • 1. Enhanced hyperpigmentation with combination chemotherapy.
    Knobf MT; Kalm D
    Oncol Nurs Forum; 1990; 17(5):762. PubMed ID: 2251197
    [No Abstract]   [Full Text] [Related]  

  • 2. Sclerotic and retracted supravenous hyperpigmentation associated with combination chemotherapy for metastatic breast carcinoma.
    Chen GY; Lee JY; Chen WC
    Br J Dermatol; 2005 Jun; 152(6):1383-5. PubMed ID: 15949026
    [No Abstract]   [Full Text] [Related]  

  • 3. Serpentine supravenous pigmentation. A rare vasculo-cutaneous effect induced by systemic 5-fluorouracil.
    Rao R; Balachandran C
    Indian J Dermatol Venereol Leprol; 2010; 76(6):714-5. PubMed ID: 21079327
    [No Abstract]   [Full Text] [Related]  

  • 4. Atypical moles in a patient undergoing chemotherapy with oral 5-fluorouracil prodrug.
    Fukushima S; Hatta N
    Br J Dermatol; 2004 Sep; 151(3):698-700. PubMed ID: 15377362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sequential combination chemotherapy in metastatic cancer of the breast].
    Leone BA; Rabinovich MG; Strauss E; Arévalo E
    Medicina (B Aires); 1984; 44(1):15-22. PubMed ID: 6549523
    [No Abstract]   [Full Text] [Related]  

  • 6. Reticulate Hyperpigmentation secondary to 5-fluorouracil and idarubicin.
    Jogi R; Garman M; Pielop J; Orengo I; Hsu S
    J Drugs Dermatol; 2005; 4(5):652-6. PubMed ID: 16167426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination regimen of epirubicin, vinorelbine and 5-fluorouracil continuous infusion as first-line chemotherapy in anthracycline-naive metastatic breast cancer patients.
    Berruti A; Bitossi R; Bottini A; Bonardi S; Donadio M; Nigro C; Bertetto O; Danese S; Bertone E; Sarobba MG; Farris A; Katsaros D; Castiglione F; Volpe T; Lattuada S; Mancarella S; Dogliotti L
    Eur J Cancer; 2005 Jan; 41(2):249-55. PubMed ID: 15661550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Results of a study on fatigue in breast cancer patients receiving adjuvant chemotherapy: the first four days after treatment are the worst].
    de Jong N; Kester AD; Schouten HC; Abu-Saad HH; Courtens AM
    Pflege Z; 2007 Nov; 60(11):620-5. PubMed ID: 18062627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitomycin C and 5-fluorouracil as second choice treatment in advanced breast cancer patients.
    Ardizzoni A; Pronzato P; Conte PF; Rosso R
    Chemioterapia; 1984 Apr; 3(2):83-5. PubMed ID: 6442624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasound enhanced skin-lightening effect of vitamin C and niacinamide.
    Hakozaki T; Takiwaki H; Miyamoto K; Sato Y; Arase S
    Skin Res Technol; 2006 May; 12(2):105-13. PubMed ID: 16626384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous hyperpigmentation during therapy with hydroxychloroquine.
    Amichai B; Gat A; Grunwald MH
    J Clin Rheumatol; 2007 Apr; 13(2):113. PubMed ID: 17414546
    [No Abstract]   [Full Text] [Related]  

  • 12. A case of manic episode during treatment with 5-fluorouracil, epirubicin and cyclophosphamide for breast cancer.
    Pacchiarotti I; Mazzarini L; Pellegrini P; Venturelli V; Sani G; Sánchez-Moreno J; Mancinelli I; Tatarelli R; Kotzalidis GD; Girardi P
    Gen Hosp Psychiatry; 2007; 29(5):461-3. PubMed ID: 17888816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma: a randomized phase II trial.
    Hainsworth JD; Jolivet J; Birch R; Hopkins LG; Greco FA
    Cancer; 1997 Feb; 79(4):740-8. PubMed ID: 9024712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Primary chemotherapy of metastatic breast carcinoma with bendamustine hydrochloride, methotrexate and fluorouracil versus cyclophosphamide, methotrexate and fluorouracil].
    Ruffert K
    Zentralbl Chir; 1998; 123 Suppl 5():156-8. PubMed ID: 10063603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
    Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
    Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical and pharmacologic agents that cause hyperpigmentation or hypopigmentation of the skin.
    Lerner EA; Sober AJ
    Dermatol Clin; 1988 Apr; 6(2):327-37. PubMed ID: 3288388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The case for adjuvant CMF chemotherapy in breast cancer. Has it been made?
    Levitt SH; Potish RA
    Cancer Clin Trials; 1981; 4(4):363-9. PubMed ID: 7032731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination chemotherapy with carboplatin, cyclophosphamide and fluorouracil in advanced breast cancer.
    Closon MT; Verbeke L; Kains JP; Tijtgat J; Schallier D
    Anticancer Res; 1995; 15(2):591-5. PubMed ID: 7539240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conserving surgery enhances late toxicities: long-term results of the ARCOSEIN multicenter randomized study.
    Toledano A; Garaud P; Serin D; Fourquet A; Bosset JF; Breteau N; Body G; Azria D; Le Floch O; Calais G
    Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):324-32. PubMed ID: 16542788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vinorelbine and 5-fluorouracil bolus and/or continuous venous infusion plus levofolinic acid as second-line chemotherapy for metastatic breast cancer: an analysis of results in clinical practice of the Gruppo Oncologico Italia Meridionale (GOIM).
    Gebbia V; Caruso M; Borsellino N; Ajello R; Tirrito ML; Chiarenza M; Valenza R; Verderame F; Varvara F; Marrazzo A; Bajardi E; Ferrao F; Bordonaro R; Tralongo P
    Anticancer Res; 2006; 26(4B):3143-50. PubMed ID: 16886648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.